Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Mycapssa (octreotide)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(10)
News
Trials
Company:
Chiesi
Drug class:
SSTR agonist
Related drugs:
‹
lanreotide prolonged-release subcutaneous (2)
pasireotide (1)
DG3173 (1)
octreotide subcutaneous depot (0)
octreotide extended release (0)
vapreotide (0)
pasireotide long acting release (0)
VMT-𝛼-NET (0)
Debio 4126 (0)
octreotide acetate (0)
octreotide acetate solution for injection (0)
MTD201 (0)
lanreotide prolonged-release subcutaneous (2)
pasireotide (1)
DG3173 (1)
octreotide subcutaneous depot (0)
octreotide extended release (0)
vapreotide (0)
pasireotide long acting release (0)
VMT-𝛼-NET (0)
Debio 4126 (0)
octreotide acetate (0)
octreotide acetate solution for injection (0)
MTD201 (0)
›
Associations
(10)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Thymic Carcinoma
No biomarker
Thymic Carcinoma
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
No biomarker
Thymic Carcinoma
No biomarker
Thymic Carcinoma
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
No biomarker
Thymoma
No biomarker
Thymoma
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
prednisone + octreotide
Sensitive: A2 - Guideline
prednisone + octreotide
Sensitive
:
A2
No biomarker
Thymoma
No biomarker
Thymoma
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
SSTR positive
Neuroendocrine Tumor
SSTR positive
Neuroendocrine Tumor
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
octreotide
Sensitive: A2 - Guideline
octreotide
Sensitive
:
A2
SSTR5 expression
Neuroendocrine Tumor
SSTR5 expression
Neuroendocrine Tumor
octreotide
Sensitive: C3 – Early Trials
octreotide
Sensitive
:
C3
octreotide
Sensitive: C3 – Early Trials
octreotide
Sensitive
:
C3
SSTR2 expression
Neuroendocrine Tumor
SSTR2 expression
Neuroendocrine Tumor
octreotide
Sensitive: C3 – Early Trials
octreotide
Sensitive
:
C3
octreotide
Sensitive: C3 – Early Trials
octreotide
Sensitive
:
C3
SSTR5 expression
Non Small Cell Lung Cancer
SSTR5 expression
Non Small Cell Lung Cancer
paclitaxel + octreotide
Sensitive: D – Preclinical
paclitaxel + octreotide
Sensitive
:
D
paclitaxel + octreotide
Sensitive: D – Preclinical
paclitaxel + octreotide
Sensitive
:
D
SSTR2 expression
Non Small Cell Lung Cancer
SSTR2 expression
Non Small Cell Lung Cancer
paclitaxel + octreotide
Sensitive: D – Preclinical
paclitaxel + octreotide
Sensitive
:
D
paclitaxel + octreotide
Sensitive: D – Preclinical
paclitaxel + octreotide
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login